Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast
PLEASANTON, Calif., Feb. 14, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16.
Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 4:00 p.m., Eastern Standard Time (1:00 p.m., Pacific Standard Time).
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web site at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.
SOURCE Thoratec Corporation
More by this Source
Thoratec Announces Presentations At Investor Conferences For March 2014
Feb 26, 2014, 12:02 ET
Thoratec® Reports Fourth Quarter 2013 Results
Feb 04, 2014, 16:02 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.